% | $
Quotes you view appear here for quick access.

Novadel Pharma Inc. Message Board

  • leonia5pbb leonia5pbb Feb 14, 2013 5:58 PM Flag

    NovaDel was awarded a grant 2 years ago, NVDL should bring back Duromist now

    NovaDel Pharma Inc. Awarded $244,479 Grant from Qualifying

    NovaDel Pharma Inc. Awarded $244,479 Grant from Qualifying Therapeutic
    Discovery Project Program

    Business Wire

    BRIDGEWATER, N.J. -- November 03, 2010

    NovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company
    developing oral spray formulations for a broad range of marketed
    pharmaceutical products, today announced that it has been awarded a $244,479
    grant under the IRS’ Qualifying Therapeutic Discovery Project, which it
    expects to receive in January 2011. The grant, which targets therapeutic
    discovery projects that show a reasonable potential to result in new therapies
    to treat areas of unmet medical need or to treat chronic or acute diseases and
    conditions or to result in reduced health care costs, was awarded to NovaDel
    to help fund the further clinical development of Duromist™. Duromist is
    NovaDel’s oral spray formulation of sildenafil, and is being developed for the
    treatment of erectile dysfunction.

    ”We are delighted that the potential advantages of Duromist have been
    recognized through the award of this grant,” commented Craig Johnson, Senior
    Vice President and CFO of NovaDel Pharma Inc.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.008-0.001(-5.88%)May 23 1:38 PMEDT